Diabetes mellitus
Conditions
Interventions
This is a randomized, double-blind clinical study. A total of 39 people meeting the eligibility criteria were randomly assigned to two groups. Both the researchers who evaluated the outcomes and the p
E06.470
Sponsors
Centro de Ciências Biológicas e da Saúde CCBS - Universidade Estadual do Oeste do Paraná
Centro de Ciências Biológicas e da Saúde CCBS - Universidade Estadual do Oeste do Paraná
Eligibility
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients of both sexes with Periodontitis stages 1, 2, 3 or 4, grade B or C, presenting bleeding on probing and gingival inflammation. Patients must have the pathophysiological condition of Type II Diabetes Mellitus (diagnosed by endocrinologists) and use systemic Metformin. Patients who agree to participate in the study, signing the informed consent form. Patient aged between 18 and 70 years
Exclusion criteria
Exclusion criteria: Patients with a positive history in the last 6 months of broad-spectrum antibiotic therapy, steroidal anti-inflammatory drugs or immunosuppressive therapy in the 3 months prior to the study. Pregnant or lactating. History of periodontal treatment in the last 6 months. Smoking or quitting the habit for less than 5 months. Patients who have less than 4 teeth or have misaligned teeth in the dental arch. Patient under 18 years old or over 70 years old
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected Outcome 1: It is expected to improve the clinical parameters of clinical probing depth and clinical attachment level, decrease the amount of interleukin-17 present in the crevicular fluid. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactBruna Ferreira
Universidade Estadual do Oeste do Paraná
Outcome results
None listed